Secret Dry Spray Antiperspirant Recalled Over Manufacturing Facility Defect
Secret Dry Spray antiperspirant is being recalled due to CGMP violations at the manufacturing facility where other lots were found contaminated with benzene. No illnesses have been reported.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall for CGMP violations and facility contamination with benzene, a high-risk hazard. No illnesses or injuries have been reported, making this a theoretical risk-of-harm situation that meets the High severity criterion.
Plain-English summary
The Procter & Gamble Company is recalling Secret Dry Spray antiperspirant (Rose scent, 3.8 oz, NDC 69423-380-10) due to current Good Manufacturing Practice (CGMP) deviations identified at the manufacturing facility.
Other lots manufactured at the same facility were found to be contaminated with benzene. This recall affects products with lot codes expiring through September 2023.
The product has been distributed nationwide in the USA and Puerto Rico, as well as internationally in Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, and Guyana. Consumers should stop using the affected product immediately.
The recalled product
- Product
- Secret Dry Spray, Aluminum chlorohydrate 23.5%, Antiperspirant, Rose, Topical spray can Net Wt 3.8 oz (107 g), Dist. by: Procter & Gamble, Cincinnati, OH 45202. NDC: 69423-380-10, UPC 0 37000 79884 2
- Manufacturer
- The Procter & Gamble Company
- Category
- Drug — Antiperspirant / Topical
- Hazard
- cgmp-deviation
- benzene-contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots with expiry through September 2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27